Clinical value of 18F-FDG PET/CT in detecting viable tumor, recurrence and metastases of hepato-cellular carcinoma after transcatheter arterial chemoembolization

胡四龙,章英剑,朱蓓玲,施伟,孟志强,李蓓蕾,蒋国梁

DOI: https://doi.org/10.3760/cma.j.issn.0253-9780.2009.03.007

2009-01-01

Abstract:Objective Accurate evaluation of treatment result of transcatheter arterial chemoembo-lization (TACE) in patients with hepatocellular carcinoma (HCC) by conventional imaging is difficult. The objective of this study was to investigate the clinical value of 18F-fluorodeoxyglucose (FI)G) PET/CT for de-tecting residual viable tumor, recurrence and metastases in patients with HCC after TACE. Methods Twenty-two patients with HCC after TACE were investigated with 18F-FDG PET/CT. The accuracy of FDG PET/CT was determined by the histopathological results or evidences of clinical follow-up. Results Of all 22 HCC patients after TACE, 18 had intra- and (or) extrahepatic lesions, detected by FDG PET/CT. Six-teen patients had intrahepatic FDG-avid lesion(s). Of the 16 patients, five had intrahepatic FDG-avid le-sions located at both lipiodol-rich and -deprive regions, 13 had associated extrahepatic metastases. Of the two HCC patients who had no intrahepatic FDG-avid lesion, there were extrahepatic FDG-avid lesions at the retroperitoneal lymph nodes. In all, 15 HCC had extrahepatic lesions identified by FDG PET/CT. There were lung and lymph nodes (n = 9), bone (n = 2), tumor thrombus at portal vein (n - 1) and diaphragm crus (n = 1). Two patients were false negative. The sensitivity, specificity, accuracy of FDG PET/CT in detecting intra- and (or) extrahepatic lesions after TACE were 88.9% (16/18) vs 94.7 % (18/19), 4/4 vs 3/3, and90.9% (20/22) vs95.5% (21/22), respectively. Conclusion 18F-FDG PET/CT is poten-tial useful for detection both intra- and (or) extrahepatic lesions in HCC patients after TACE.